Detalhe da pesquisa
1.
SERINC5 Can Enhance Proinflammatory Cytokine Production by Primary Human Myeloid Cells in Response to Challenge with HIV-1 Particles.
J Virol
; 95(9)2021 04 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33597208
2.
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists.
J Gen Virol
; 100(2): 278-288, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30566072
3.
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
J Biol Chem
; 292(33): 13702-13713, 2017 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28659343
4.
The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
J Virol
; 90(23): 10915-10927, 2016 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27681140
5.
Correction: The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
J Biol Chem
; 294(49): 18951, 2019 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31811051
6.
SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation.
J Innate Immun
; 12(5): 399-409, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31935717
7.
Patient-Derived HIV-1 Nef Alleles Reveal Uncoupling of CD4 Downregulation and SERINC5 Antagonism Functions of the Viral Pathogenesis Factor.
J Acquir Immune Defic Syndr
; 85(2): e23-e26, 2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32541384